Tumor-infiltrating lymphocytes, particularly the balance between CD8+ T cells and CCR4+ regulatory T cells, affect the survival of patients with oral squamous cell carcinoma

被引:142
作者
Watanabe, Yoshiko
Katou, Fuminori [1 ]
Ohtani, Haruo [2 ]
Nakayama, Takashi [3 ]
Yoshie, Osamu [3 ]
Hashimoto, Kenji
机构
[1] Hamamatsu Univ Sch Med, Dept Oral & Maxillofacial Surg, Higashi Ku, Hamamatsu, Shizuoka 4313125, Japan
[2] Mito Med Ctr, Dept Pathol, Ibaraki, Japan
[3] Kinki Univ, Dept Microbiol, Osaka, Japan
来源
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY | 2010年 / 109卷 / 05期
关键词
PROGNOSTIC-FACTOR; OVARIAN-CANCER; HEPATOCELLULAR-CARCINOMA; COLORECTAL-CANCER; CERVICAL-CANCER; POOR SURVIVAL; EFFECTOR; RECRUITMENT; IMMUNOSURVEILLANCE; SUPPRESSION;
D O I
10.1016/j.tripleo.2009.12.015
中图分类号
R78 [口腔科学];
学科分类号
100302 [口腔临床医学];
摘要
Objective. The objective of this study was to clarify the prognostic significance of tumor-infiltrating lymphocytes (TILs) in oral squamous cell carcinoma (OSCC); the present study analyzed various TIL-related parameters. Study design. Immunohistochemistry was performed in 87 patients with OSCC for the following TIL-related parameters: nest-CD8(+) T cells, stromal CD8(+) T cells, CD4(+) T cells, total regulatory T cells (Tregs), CCR4(+) Tregs, ratio of nest CD8(+) T cells/CCR4(+) Tregs, and ratio of stromal CD8(+) T cells/CCR4(+) Tregs. Results. In univariate analyses, the following parameters were associated with decreased survival: few nest-and stromal CD8(+) T cells and more stromal CCR4(+) Tregs, but not total Tregs. Low ratios of nest and stromal CD8(+) T cell/CCR4(+) Treg were associated with worse survival. In multivariate analysis, the stromal CD8(+) T cell/CCR4(+) Treg ratio was an independent prognostic factor. Conclusion. Host immune responses in the stroma of OSCC affect the survival of the patients. The in situ balance between effector T cells and regulatory T cells is the most important factor predicting survival. (Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 109: 744-752)
引用
收藏
页码:744 / 752
页数:9
相关论文
共 36 条
[1]
[Anonymous], 2005, World Health Organization Classification of Tumours: Pathology and Genetics of Head and Neck Tumours
[2]
Human peripheral blood T regulatory cells (Tregs), functionally primed CCR4+ Tregs and unprimed CCR4- Tregs, regulate effector T cells using FasL [J].
Baatar, Dolgor ;
Olkhanud, Purevdorj ;
Sumitomo, Kenya ;
Taub, Dennis ;
Gress, Ronald ;
Biragyn, Arya .
JOURNAL OF IMMUNOLOGY, 2007, 178 (08) :4891-4900
[3]
Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse [J].
Bates, Gaynor J. ;
Fox, Stephen B. ;
Han, Cheng ;
Leek, Russell D. ;
Garcia, Jose F. ;
Harris, Adrian L. ;
Banham, Alison H. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (34) :5373-5380
[4]
Comparative analysis of regulatory and effector T cells in progressively growing versus rejecting tumors of similar origins [J].
Bui, Jack D. ;
Uppaluri, Ravindra ;
Hsieh, Chyi-Song ;
Schreiber, Robert D. .
CANCER RESEARCH, 2006, 66 (14) :7301-7309
[5]
Intraepithelial CD8+ T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma:: possible association with suppression of micrometastasis [J].
Chiba, T ;
Ohtani, H ;
Mizoi, T ;
Naito, Y ;
Sato, E ;
Nagura, H ;
Ohuchi, A ;
Ohuchi, K ;
Shiiba, K ;
Kurokawa, Y ;
Satomi, S .
BRITISH JOURNAL OF CANCER, 2004, 91 (09) :1711-1717
[6]
Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells [J].
Clark, Rachael A. ;
Huang, Susan J. ;
Murphy, George F. ;
Mollet, Ilse G. ;
Hijnen, Dirkjan ;
Muthukuru, Manoj ;
Schanbacher, Carl F. ;
Edwards, Vonetta ;
Miller, Danielle M. ;
Kim, Jenny E. ;
Lambert, Jo ;
Kupper, Thomas S. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (10) :2221-2234
[7]
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival [J].
Curiel, TJ ;
Coukos, G ;
Zou, LH ;
Alvarez, X ;
Cheng, P ;
Mottram, P ;
Evdemon-Hogan, M ;
Conejo-Garcia, JR ;
Zhang, L ;
Burow, M ;
Zhu, Y ;
Wei, S ;
Kryczek, I ;
Daniel, B ;
Gordon, A ;
Myers, L ;
Lackner, A ;
Disis, ML ;
Knutson, KL ;
Chen, LP ;
Zou, WP .
NATURE MEDICINE, 2004, 10 (09) :942-949
[8]
Regulatory T cells and treatment of cancer [J].
Curiel, Tyler J. .
CURRENT OPINION IN IMMUNOLOGY, 2008, 20 (02) :241-246
[9]
The immunobiology of cancer immunosurveillance and immunoediting [J].
Dunn, GP ;
Old, LJ ;
Schreiber, RD .
IMMUNITY, 2004, 21 (02) :137-148
[10]
Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients [J].
Fu, Junliang ;
Xu, Dongping ;
Liu, Zhenwen ;
Shi, Ming ;
Zhao, Ping ;
Fu, Baoyun ;
Zhang, Zheng ;
Yang, Huiyin ;
Zhang, Hui ;
Zhou, Chunbao ;
Ya, Jinxia ;
Jin, Lei ;
Wang, Huifen ;
Yang, Yongping ;
Fu, Yang-Xing ;
Wang, Fu-Sheng .
GASTROENTEROLOGY, 2007, 132 (07) :2328-2339